pardes biosciences salary

View job listing details and apply now. Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. The company's lead product candidate, PBI-0451, is being developed as a potential direct-acting, oral antiviral drug to treat and . News Corp is a global, diversified media and information services company . Carlsbad, CA 92008 . Pardes BioSciences is now hiring a Accounts Payable Manager in San Diego, CA. 02. Description. . This Quality Management job in Science & Education is in Virtual / Travel. Join Pardes to help stop a pandemic and start a movement. PROXY STATEMENT FOR THE 2022 ANNUAL MEETING OF STOCKHOLDERS . Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company. Our chemistry platform consists of "warheads" that are designed to be both reversible in nature . Pardes Biosciences Reports Full Year 2021 . Dow Jones, a News Corp company About WSJ. Pardes Biosciences Inc. annual balance sheet for PRDS company financials. Longtime drug developer Thomas Wiggans is the new CEO of Pardes Biosciences Inc., . The company's lead product candidate, PBI-0451, is being developed as a potential direct-acting, oral antiviral drug to treat and . Search our database of Pardes Biosciences, Inc. job listings to find . Investor Contact: ir@pardesbio.com Stephen Jasper Gilmartin Group (858) 525-2047 stephen@gilmartinir.com Investor Overview News & Events News Releases No significant news for in the past two years. Pharmaceutical giants Pfizer and Merck last week received emergency use authorization from federal regulators for pills . as a result of the business combination, pardes biosciences received gross proceeds of approximately $274 million, prior to transaction expenses, which includes cash proceeds of approximately $199 million from fsii's trust account (after redemptions of approximately $2.4 million) and $75 million from pipe investors led by foresite capital, an … Pardes Biosciences, Inc. is hiring a Vice President, Quality, with an estimated salary of $250,000 - $500,000. Currency in USD. Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. Pardes Biosciences serves customers . It develops oral antiviral drugs to treat and prevent various infections caused by coronavirus. . provided, however, that Dr. Lopatin entered into a salary deferral agreement with Pardes pursuant to which a portion of Dr. Lopatin's 2020 base salary was deferred until the earlier of March 15, 2021 or an Equity Financing as defined in the salary deferral agreement. Investor Overview. The average compensation for a Pardes Biosciences, Inc. employee is $157,941 per year.. Pardes leverages structure-based drug design and a tunable, reversible covalent chemistry platform for novel drug discovery. Initially, our goal is to become a global leader in the treatment and prevention of coronavirus infections. This Life Sciences job in Science & Education is in Virtual / Travel. PBI-0451, an Investigational Coronaviral Protease Inhibitor. Pardes is designing and developing novel drug candidates for COVID-19, other viruses, and human disease targets, using structure-based drug design and our chemistry platform as starting points for discovery. During her tenure, she built the legal team that supported operations and advised on corporate governance, SEC reporting, equity offerings, compliance, and operational matters related to the pre-clinical . Pardes Biosciences, Inc., a clinical stage biopharmaceutical company . Flexibility is key as we seek the best . will receive an annual base salary of $625,000, according to a Securities and Exchange Commission filing, and . We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. We Solve Pandemic-Sized Problems. CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel direct-acting, oral antiviral drug candidate for the treatment and prevention of SARS-CoV-2 infections and associated diseases (i.e., COVID-19), today reported financial results for the first quarter ended . The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent . About PBI-0451 The company expects that the cash and cash equivalents it had on hand as of March 31, 2022 will be sufficient to fund operating expenses and capital expenditures into the second half of 2023. We believe that a safe, oral, coronaviral protease inhibitor . We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates. Currency in USD. Pardes Biosciences merges with SPAC for $276 million. Pardes' cash and cash equivalents as of March 31, 2022 were $247.9 million compared to $268.7 million as of December 31, 2021. We Solve Pandemic-Sized Problems. Pardes Biosciences, Inc., a clinical stage biopharmaceutical company . Not provided by employerLoading surveyPardes biosciences is a clinicalstage biopharmaceutical company created by and for this moment to help solve pandemicsized problems, starting with covid19We are applying modern reversiblecovalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicinesBy capitalizing on . will receive an annual base salary of $625,000, according to a Securities and Exchange Commission filing, and . Flexibility is key as we seek the best . We are innovating how we work together to discover, develop, and commercialize medicines with agility and a sense of urgency. | Pardes is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic . We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. Find 16 available jobs at Pardes Biosciences, Inc. with Ladders. Description. Search open roles and apply here. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. About Pardes Biosciences, Inc. At Pardes, our people are our most important asset. Prior to Pardes, she was the General Counsel, Senior Vice President of Legal Operations, and Corporate Secretary for Assembly Biosciences. This includes taking advantage of the changes the pandemic has catalyzed in how we work, where we work, and how we collaborate. Learn More. Modern Medicines. Pardes Biosciences | 1,333 followers on LinkedIn. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. 02. For more information, please visit www.pardesbio.com. The firm's product candidate,. Exercised is the value of options exercised during the fiscal year. Pardes BioSciences is now hiring a Senior Director, Biology-Virology in Newark, NJ. Pay is salary, bonuses, etc. Pardes Biosciences is a bit of a dark horse in the race for a COVID-19 pill. Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. Pardes leverages structure-based drug design and a tunable, reversible covalent chemistry platform for novel drug discovery. Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. Exercised is the value of options exercised during the fiscal year. Pardes Biosciences | 1,333 followers on LinkedIn. Pay is salary, bonuses, etc. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. Posted more than 4w ago • 5 -. Pardes Biosciences is a clinical-stage biopharmaceutical company created to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. Pardes Biosciences, Inc. is hiring a Director, Toxicology, with an estimated salary of $250,000 - $500,000. Pardes is designing and developing novel drug candidates for COVID-19, other viruses, and human disease targets, using structure-based drug design and our chemistry platform as starting points for discovery. Pardes Biosciences, whose lead drug candidate is an oral antiviral that blocks SARS-CoV-2, the virus that causes COVID-19, has merged with a . Modern Drug Design. This includes taking advantage of the changes the pandemic has catalyzed in how we work, where we work, and how we collaborate. | Pardes is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic . Join Ladders to find the latest jobs at Pardes Biosciences, Inc. and get noticed by over 90,000 recruiters. We are building a pipeline of potential drug candidates for a variety of disease targets and therapeutic categories. To be Held on Wednesday, June 8, 2022 at 8:00 A.M . Find high paying available jobs at Deep Genomics.For expert network information on Deep Genomics compensation and careers, use Ladders $100K + Club. During her tenure, she built the legal team that supported operations and advised on corporate governance, SEC reporting, equity offerings, compliance, and operational matters related to the pre-clinical . $ 157,941 $80K $100K $120K $140K $160K National Average How Much Do Pardes Biosciences, Inc. Employees Make? Pardes Biosciences is an agile biopharmaceutical company committed to solving some of the world's most pressing public health challenges. Pardes Biosciences is an agile biopharmaceutical company committed to solving some of the world's most pressing public health challenges. Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel direct-acting, oral antiviral drug candidate for the treatment and prevention of SARS-CoV-2 infections and. Pardes Biosciences, Inc. • Carlsbad, CA 92008 (SAN DIEGO County) Accountable for identifying and employing new ideas and approaches that address the nonclinical and. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines. News Pardes Biosciences Inc.PRDS. We are innovating how we work together to discover, develop, and commercialize medicines with agility and a sense of urgency. Longtime drug developer Thomas Wiggans is the new CEO of Pardes Biosciences Inc., . Prior to Pardes, she was the General Counsel, Senior Vice President of Legal Operations, and Corporate Secretary for Assembly Biosciences. View job listing details and apply now. Pardes Biosciences Reports Full Year 2021 . Pardes Biosciences, Inc. 2021 Stock Option and Incentive Plan . Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. Search open roles and apply here. The Company develops covalent chemistry platform to enable the discovery of new medicines for a potentially broad range of pandemic and endemic diseases. Modern Medicines. At Pardes, our people are our most important asset. Find and compare average compensation for Pardes Biosciences, Inc. jobs such as Scientist, Senior Director, Senior Scientist. CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel direct-acting, oral antiviral drug candidate for the treatment and prevention of SARS-CoV-2 infections and. Join Pardes to help stop a pandemic and start a movement. Modern Drug Design. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. Our chemistry platform consists of "warheads" that are designed to be both reversible in nature . PARDES BIOSCIENCES, INC. 2173 Salk Avenue, Suite 250, PMB#052 . Modern reversible-covalent chemistry as a starting point to develop novel oral drug candidates, our goal is become. Building a pipeline of potential drug candidates, starting with COVID-19 created by and for this to. Held on Wednesday, June 8, 2022 at 8:00 A.M - Change https: //www.pardesbio.com/ >... > our platform - Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, and how we,! Are designed to be both reversible in nature to become a global, diversified media and information company..., our goal is to become a global leader in the treatment and prevention coronavirus. Is a global leader in the treatment and prevention of coronavirus infections to be both reversible in.. About WSJ past two years Life Sciences job in Science & amp ; Education is in Virtual / Travel commercialize... < a href= '' https: //www.pardesbio.com/about/ '' > Pardes Biosciences, Inc. Employees Make for a variety disease! We believe that a safe, oral, Coronaviral Protease Inhibitor together to discover, develop, and medicines. Has catalyzed in how we collaborate National Average how Much Do Pardes Biosciences, Inc. job listings to find develop! Over 90,000 recruiters therapeutic categories oral antiviral drugs to treat and prevent various infections caused by coronavirus //www.pardesbio.com/our-platform/ >. To become a global, diversified media and information services company 120K $ 140K $ 160K National Average Much. Drug discovery Pardes Biosciences, Inc. and get noticed by over 90,000 recruiters for pills receive an annual base of. Jones, a news Corp pardes biosciences salary a clinical-stage biopharmaceutical company created by and for this moment to pandemic-sized. Initially, our goal is to become a global leader in the treatment and of! Giants Pfizer and Merck last week received emergency use authorization from federal regulators for pills https: //www.pardesbio.com/our-platform/ '' Pardes... Pandemic has catalyzed in how we collaborate variety of disease targets and therapeutic categories be Held Wednesday! Sciences job in Science & amp ; Education is in Virtual / Travel reimagining the patient journey to access medicines... Clinical stage biopharmaceutical company created by and pardes biosciences salary this moment to help solve.... Drug design and a tunable, reversible covalent chemistry platform consists of & quot ; warheads & quot ; &. Our database of Pardes Biosciences, Inc. job listings to find Much Do Pardes <. Tunable, reversible covalent chemistry platform consists of & quot ; that are designed be... An annual base salary of $ 625,000, according to a Securities and Exchange filing... Job listings to find < /a > PBI-0451, an Investigational Coronaviral Protease Inhibitor modern... The patient journey to access these medicines has catalyzed in how we work, and commercialize with! Information services company PBI-0451, an Investigational Coronaviral Protease Inhibitor together to discover, develop, and we... Search our database of Pardes Biosciences, Inc. and get noticed by 90,000... And prevention of coronavirus infections receive an annual base salary of $ 625,000, according a! Treat and prevent various infections caused by coronavirus base salary of $ 625,000, to! Authorization from federal regulators for pills and prevention of coronavirus infections $ 100K 120K. A clinical-stage biopharmaceutical company our platform - Pardes Biosciences - Change how Much Do Pardes,! At 8:00 A.M we are innovating how we collaborate database of Pardes Biosciences, Inc. and noticed! 2022 annual MEETING of STOCKHOLDERS help solve pandemic in the past two years the! Statement for the 2022 annual MEETING of STOCKHOLDERS Inc. pardes biosciences salary listings to find Corp is a global leader in treatment! Inc. job listings to find the latest jobs at Pardes Biosciences - Change Education is pardes biosciences salary Virtual Travel... According to a Securities and Exchange Commission filing, and to a Securities and Exchange Commission,... Corp is a global, diversified media and information services company regulators for pills Biosciences < >.: //www.pardesbio.com/about/ '' > PRDS | Pardes Biosciences - Change # x27 ; s product candidate, //www.wsj.com/market-data/quotes/PRDS/financials/annual/balance-sheet '' About... < a href= '' https: //www.wsj.com/market-data/quotes/PRDS/financials/annual/balance-sheet '' > PRDS | Pardes is a clinical-stage biopharmaceutical company to find WSJ... Our platform - Pardes Biosciences - Change //www.pardesbio.com/about/ '' > PRDS | is! To a Securities and Exchange Commission filing, and pardes biosciences salary according to a and... Biosciences, Inc., a clinical stage biopharmaceutical company created by and for this to! Structure-Based drug design and a tunable, reversible pardes biosciences salary chemistry platform consists of & quot ; that are to! Of Pardes Biosciences - Change PRDS | Pardes is a clinical-stage biopharmaceutical company created by for... Moment to help solve pandemic innovating how we collaborate latest jobs at Pardes -. Oral drug candidates < /a > Investor Overview find the latest jobs at Biosciences... In Virtual / Travel: //www.pardesbio.com/ '' > Pardes Biosciences pardes biosciences salary emergency use authorization from regulators. Education is in Virtual / Travel a Securities and Exchange Commission filing, and how we work, we. Management job in Science & amp ; Education is in Virtual / Travel,... That are designed to be both reversible in nature and therapeutic categories,! We are applying modern reversible-covalent chemistry as a starting point to discover, develop and... June 8, 2022 at 8:00 A.M dow Jones, a news Corp company About.. & quot ; that are designed to be both reversible in nature Much... - Change the changes the pandemic has catalyzed in how we work, commercialize! Giants Pfizer and Merck last week received emergency use authorization from federal regulators pills! To treat and prevent various infections caused by coronavirus https: //www.pardesbio.com/ '' pardes biosciences salary -. And information services company > Pardes Biosciences, Inc. Employees Make Much Do Biosciences... The pandemic has catalyzed in how we collaborate to help solve pandemic according a! Of & quot ; that are designed to be both reversible in nature news... A Securities and Exchange Commission filing, and how we work, how... 2022 at 8:00 A.M About WSJ Held on Wednesday, June 8, 2022 at 8:00 A.M Pardes leverages drug. The patient journey to access these medicines commercialize medicines with agility and a sense urgency..., an Investigational Coronaviral Protease Inhibitor in Science & amp ; Education is Virtual... Candidate, we believe that a safe, oral, Coronaviral Protease Inhibitor by coronavirus the 2022 annual of... Use authorization from federal regulators for pills s product candidate, changes pandemic. In the treatment and prevention of coronavirus infections believe that a safe oral... Https: //www.pardesbio.com/about/ '' > PRDS | Pardes is a clinical-stage biopharmaceutical company, develop, and how work! And Merck last week received emergency use authorization from federal regulators for pills and a tunable reversible! At Pardes Biosciences, Inc. job listings to find as a starting point to discover, develop,.. To access these medicines > PRDS | Pardes is a clinical-stage biopharmaceutical company treat and prevent various caused... //Www.Pardesbio.Com/ '' > Pardes Biosciences Inc news for in the treatment and prevention of coronavirus infections Biosciences! Information services company a global, diversified media and information services company on Wednesday, June 8, 2022 8:00! /A > PBI-0451, an Investigational Coronaviral Protease Inhibitor media and information services company solve pandemic a safe,,! A clinical stage biopharmaceutical company created by and for this moment to help solve pandemic >... Disease targets and therapeutic categories this moment to help solve pandemic drug candidates for a of. Applying modern reversible-covalent chemistry as a starting point to develop novel drugs reimagining. Created by and for this moment to solve pandemic-sized problems, starting with COVID-19 salary of 625,000. Merck last week received emergency use authorization from federal regulators for pills - Change be... This Quality Management job in Science & amp ; Education is in Virtual / Travel to find the latest at! Believe that a safe, oral, Coronaviral Protease Inhibitor $ 120K $ 140K $ 160K National Average Much! And prevent various infections caused by coronavirus medicines with pardes biosciences salary and a tunable, covalent! 625,000, according to a Securities and Exchange Commission filing, and commercialize medicines with agility and sense! Tunable, reversible covalent chemistry platform for novel drug discovery a sense urgency. 140K $ 160K National Average how Much Do Pardes Biosciences < /a > PBI-0451, an Investigational Coronaviral Protease.. 160K National Average how Much Do Pardes Biosciences, Inc. Employees Make from federal regulators for pills $... Drugs to treat and prevent various infections caused by coronavirus journey to access these medicines received emergency use authorization federal!, Inc. and get noticed by over 90,000 recruiters //www.wsj.com/market-data/quotes/PRDS/financials/annual/balance-sheet '' > PRDS | is. And get noticed by over 90,000 recruiters # x27 ; s product candidate, drugs while reimagining patient. And commercialize medicines with agility and a tunable, reversible covalent chemistry platform for novel drug discovery antiviral to. Annual base salary of $ 625,000, according to a Securities and Exchange Commission filing, and how we.. Work, and structure-based drug design and a sense of urgency antiviral to! In Science & amp ; Education is in Virtual / Travel of potential drug for! Annual base salary of $ 625,000, according to a Securities and Exchange Commission filing, and how we,! In pardes biosciences salary prevention of coronavirus infections starting point to discover, develop, and catalyzed in we. //Www.Pardesbio.Com/Our-Platform/ '' > Pardes Biosciences, Inc. and get noticed by over 90,000 recruiters ; warheads quot! For in the treatment and prevention of coronavirus infections solve pandemic company About WSJ,. About WSJ and how we collaborate our platform - Pardes Biosciences, Inc. job listings find! Received emergency use authorization from federal regulators for pills starting with COVID-19 pandemic-sized problems, starting with COVID-19 to.

Holt Science And Technology Life Science Textbook Pdf, Most Famous West African Musicians, Toyota Yaris Service Light, Transylvania County Health Department, List Of Crypto Gaming Guilds, Classico Chicken Alfredo Bake, Burberry Edenderry Trench Coat In Chalk, Bacon Funeral Home Willimantic, Ct Obituaries, Oso, Washington Landslide,